Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the prevention of cerebrovascular and ...(PERFORM) study

MG Bousser, P Amarenco, A Chamorro, Perform STUDY, K Koivisto

    Research output: Contribution to journalArticleScientificpeer-review

    Original languageEnglish
    Pages (from-to)509-518
    JournalCEREBROVASCULAR DISEASES
    Volume27
    Issue number5
    Publication statusPublished - 2009
    Publication typeA1 Journal article-refereed

    Cite this